Global and United States Veterinary Medicines Market Report & Forecast 2023-2029
Global and United States Veterinary Medicines Market Report & Forecast 2023-2029
The Veterinary Medicines Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Veterinary Medicines Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Veterinary Medicines market size in 2022 is XX million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Veterinary Medicines market include Archer-Daniels-Midland Company, Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC., Evonik Industries AG, and Elanco Animal Health Incorporated. The share of the top 3 players in the Veterinary Medicines market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Veterinary Medicines market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Drugs accounted for XX% of Veterinary Medicines market in 2022. Vaccines share of XX%.
Companion Animals accounted for XX% of the Veterinary Medicines market in 2022. Livestock Animals accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
On The Basis of Regions, The Report Has Segmented the Market into The Following Key Regions:
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Key Players Driving the Market:
Archer-Daniels-Midland Company
Boehringer Ingelheim International GmbH
Dechra Pharmaceuticals PLC.
Evonik Industries AG
Elanco Animal Health Incorporated
By Product Type, the market is primarily segmented into:
Drugs
Vaccines
Medicated Feed Additives
By Applications, the market is segmented into:
Companion Animals
Livestock Animals
Table of Content
1 Study Coverage
1.1 Veterinary Medicines Product Introduction
1.2 Global Veterinary Medicines Outlook 2018 VS 2023 VS 2029
1.3 United States Veterinary Medicines Outlook 2018 VS 2023 VS 2029
1.4 Veterinary Medicines Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Veterinary Medicines in Global, 2018-2029
1.4.2 The Growth Rate of Veterinary Medicines Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Veterinary Medicines Market Dynamics
1.5.1 Veterinary Medicines Market Trends
1.5.2 Veterinary Medicines Market Drivers
1.5.3 Veterinary Medicines Market Challenges
1.5.4 Veterinary Medicines Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Veterinary Medicines Competitor Landscape by Company
2.1 Global Veterinary Medicines Market Size by Company
2.1.1 Top Global Veterinary Medicines Player Ranked by Revenue (2023)
2.1.2 Global Veterinary Medicines Revenue by Player (2018-2023)
2.2 Global Veterinary Medicines Concentration Ratio (CR)
2.2.1 Veterinary Medicines Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Veterinary Medicines in 2023
2.3 Global Veterinary Medicines Business Distribution, Business Type
2.3.1 Global Veterinary Medicines Players, Headquarters and Distribution
2.3.2 Players Veterinary Medicines Business Type
2.3.3 Date of International Players Enter into Veterinary Medicines Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Veterinary Medicines Market Size by Company
2.5.1 Top United States Veterinary Medicines Player s Ranked by Revenue (2023)
2.5.2 United States Veterinary Medicines Revenue by Player (2018-2023)
3 Veterinary Medicines Market Segment by Type
3.1 Veterinary Medicines Market Segment by Type
3.2 Global Veterinary Medicines Market Size by Type
3.3 United States Veterinary Medicines Market Size by Type
4 Veterinary Medicines Market Segment by Application
4.1 Veterinary Medicines Market Segment by Application
4.2 Global Veterinary Medicines Market Size by Application
4.3 United States Veterinary Medicines Market Size by Application
5 Global Veterinary Medicines Market Size by Region
5.1 Global Veterinary Medicines Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Veterinary Medicines Market Size in Value by Region (2018-2029)
5.2.1 Global Veterinary Medicines Revenue by Region: 2018-2023
5.2.2 Global Veterinary Medicines Revenue by Region: 2023-2029
5.3 Global Veterinary Medicines Market Size in Volume by Region (2018-2029)
5.3.1 Global Veterinary Medicines Volume by Region: 2018-2023
5.3.2 Global Veterinary Medicines Volume by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Veterinary Medicines Market Size YoY Growth 2018-2029
6.1.2 North America Veterinary Medicines Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Veterinary Medicines Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Veterinary Medicines Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Veterinary Medicines Market Size YoY Growth 2018-2029
6.3.2 Europe Veterinary Medicines Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Veterinary Medicines Market Size YoY Growth 2018-2029
6.4.2 Latin America Veterinary Medicines Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Veterinary Medicines Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Veterinary Medicines Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Archer-Daniels-Midland Company
7.1.1 Archer-Daniels-Midland Company Company Details
7.1.2 Description and Business Overview
7.1.3 Veterinary Medicines Introduction
7.1.4 Archer-Daniels-Midland Company Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023)
7.1.5 Archer-Daniels-Midland Company Recent Development
7.2 Boehringer Ingelheim International GmbH
7.2.1 Boehringer Ingelheim International GmbH Company Details
7.2.2 Description and Business Overview
7.2.3 Veterinary Medicines Introduction
7.2.4 Boehringer Ingelheim International GmbH Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023)
7.2.5 Boehringer Ingelheim International GmbH Recent Development
7.3 Dechra Pharmaceuticals PLC.
7.3.1 Dechra Pharmaceuticals PLC. Company Details
7.3.2 Description and Business Overview
7.3.3 Veterinary Medicines Introduction
7.3.4 Dechra Pharmaceuticals PLC. Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023)
7.3.5 Dechra Pharmaceuticals PLC. Recent Development
7.4 Evonik Industries AG
7.4.1 Evonik Industries AG Company Details
7.4.2 Description and Business Overview
7.4.3 Veterinary Medicines Introduction
7.4.4 Evonik Industries AG Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023)
7.4.5 Evonik Industries AG Recent Development
7.5 Elanco Animal Health Incorporated
7.5.1 Elanco Animal Health Incorporated Company Details
7.5.2 Description and Business Overview
7.5.3 Veterinary Medicines Introduction
7.5.4 Elanco Animal Health Incorporated Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023)
7.5.5 Elanco Animal Health Incorporated Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Veterinary Medicines Value Chain Analysis
8.2 Veterinary Medicines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Distributors List
8.3 Veterinary Medicines Production Mode & Process
8.4 Veterinary Medicines Sales and Marketing
8.4.1 Magnetic Coupled Mixers Sales Channels
8.4.2 Magnetic Coupled Mixers Distributors
8.5 Magnetic Coupled Mixers Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 A Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 B Data Source
10.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Figure Veterinary Medicines Product Picture
Table Global Veterinary Medicines Revenue, ($), 2018 VS 2023 VS 2029
Figure Global Veterinary Medicines Market Size 2018-2029 ($)
Table United States Veterinary Medicines Revenue, ($), 2018 VS 2023 VS 2029
Figure United States Veterinary Medicines Market Size 2018-2029 ($)
Figure United States Veterinary Medicines Market Share in Global, in Value 2018-2029
Table Veterinary Medicines CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029
Table Veterinary Medicines Market Trends
Table Veterinary Medicines Market Drivers
Table Veterinary Medicines Market Challenges
Table Veterinary Medicines Market Restraints
Figure Veterinary Medicines Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Veterinary Medicines Players in Global Market, Ranking by Revenue (2023)
Table Global Veterinary Medicines Revenue by Player, ($), 2018-2023
Table Global Veterinary Medicines Revenue Share by Player, 2018-2023
Table Global Veterinary Medicines Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Veterinary Medicines in the World: Market Share by Veterinary Medicines Revenue in 2023
Table Top Players of Veterinary Medicines in Global Market, Headquarters and Distribution
Table Players Veterinary Medicines Business Type
Table Date of International Players Enter into Veterinary Medicines Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Veterinary Medicines Players in United States Market, Ranking by Revenue (2023)
Table United States Veterinary Medicines Revenue by Player, ($), 2018-2023
Table United States Veterinary Medicines Revenue Share by Player, 2018-2023
Table Global Veterinary Medicines Revenue by Type: 2023 VS 2029 ($)
Figure Global Veterinary Medicines Market Share by Type in 2023 & 2029
Figure Global Veterinary Medicines Revenue by Type (2018-2029) & ($)
Figure Global Veterinary Medicines Revenue Market Share in Value by Type (2018-2029)
Table United States Veterinary Medicines Revenue by Type: 2023 VS 2029 ($)
Figure United States Veterinary Medicines Market Share by Type in 2023 & 2029
Figure United States Veterinary Medicines Revenue by Type (2018-2029) & ($)
Figure United States Veterinary Medicines Revenue Market Share in Value by Type (2018-2029)
Table Global Veterinary Medicines Revenue by Application: 2023 VS 2029 ($)
Figure Global Veterinary Medicines Market Share by Application in 2023 & 2029
Figure Global Veterinary Medicines Revenue by Application (2018-2029) & ($)
Figure Global Veterinary Medicines Revenue Market Share in Value by Application (2018-2029)
Table United States Veterinary Medicines Revenue by Application: 2023 VS 2029 ($)
Figure United States Veterinary Medicines Market Share by Application in 2023 & 2029
Figure United States Veterinary Medicines Revenue by Application (2018-2029) & ($)
Figure United States Veterinary Medicines Revenue Market Share in Value by Application (2018-2029)
Table Global Veterinary Medicines Market Size by Region ($): 2018 VS 2023 VS 2029
Figure Global Veterinary Medicines Market Size Market Share by Region: 2018 VS 2023 VS 2029
Table Global Veterinary Medicines Revenue by Region (2018-2023) & ($)
Table Global Veterinary Medicines Revenue Forecast by Region (2023-2029) & ($)
Table Global Veterinary Medicines Revenue Market Share by Region (2018-2029)
Table Global Veterinary Medicines Volume by Region (2018-2023) & ($)
Table Global Veterinary Medicines Volume Forecast by Region (2023-2029) & ($)
Table Global Veterinary Medicines Volume Market Share by Region (2018-2029)
Figure North America Veterinary Medicines Revenue Growth Rate 2018-2029
Table North America Veterinary Medicines Revenue by Country (2018-2029) & ($)
Figure U.S. Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Canada Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Asia Pacific Veterinary Medicines Revenue Growth Rate 2018-2029 ($)
Table Asia Pacific Veterinary Medicines Revenue by Country (2018-2029) & ($)
Figure China Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Japan Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure South Korea Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure India Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Australia Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Southeast Asia Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Europe Veterinary Medicines Revenue Growth Rate 2018-2029 ($)
Table Europe Veterinary Medicines Revenue by Country (2018-2029) & ($)
Figure Germany Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure France Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure UK Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Italy Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Russia Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Latin America Veterinary Medicines Revenue Growth Rate 2018-2029 ($)
Table Latin America Veterinary Medicines Revenue by Country (2018-2029) & ($)
Figure Mexico Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Brazil Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Argentina Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Middle East and Africa Veterinary Medicines Revenue Growth Rate 2018-2029 ($)
Table Middle East and Africa Veterinary Medicines Revenue by Country (2018-2029) & ($)
Figure Turkey Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure Saudi Arabia Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Figure UAE Veterinary Medicines Revenue Growth Rate (2018-2029) & ($)
Table Archer-Daniels-Midland Company Company Details
Table Description and Business Overview
Table Veterinary Medicines Introduction
Table Archer-Daniels-Midland Company Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023) (Million USD)
Table Archer-Daniels-Midland Company Recent Development
Table Boehringer Ingelheim International GmbH Company Details
Table Description and Business Overview
Table Veterinary Medicines Introduction
Table Boehringer Ingelheim International GmbH Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023) (Million USD)
Table Boehringer Ingelheim International GmbH Recent Development
Table Dechra Pharmaceuticals PLC. Company Details
Table Description and Business Overview
Table Veterinary Medicines Introduction
Table Dechra Pharmaceuticals PLC. Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023) (Million USD)
Table Dechra Pharmaceuticals PLC. Recent Development
Table Evonik Industries AG Company Details
Table Description and Business Overview
Table Veterinary Medicines Introduction
Table Evonik Industries AG Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023) (Million USD)
Table Evonik Industries AG Recent Development
Table Elanco Animal Health Incorporated Company Details
Table Description and Business Overview
Table Veterinary Medicines Introduction
Table Elanco Animal Health Incorporated Veterinary Medicines Revenue, Sales, and Gross Margin (2018-2023) (Million USD)
Table Elanco Animal Health Incorporated Recent Development
Figure Veterinary Medicines Value Chain
Table Key Raw Materials
Table Major Distributors of Veterinary Medicines with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Veterinary Medicines Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|